Zobrazeno 1 - 10
of 332
pro vyhledávání: '"M. Steinberg"'
Autor:
Barbara G. Silverman, Osnat Ashur-Fabian, Paul J. Davis, Offer Fabian, Shmuel Giveon, Aleck Hercbergs, Daniel Yekutieli, Eilon Krashin, Martin Ellis, David M. Steinberg
Publikováno v:
Endocrine-Related Cancer. 28:705-713
Research on the association between thyroid hormone levels and cancer mortality remains limited and inconclusive. We determined the relation of thyroid stimulating hormone (TSH), free T4 (FT4), and free T3 (FT3) levels with mortality in overall cance
Publikováno v:
AJSP: Reviews and Reports. 26:188-193
Autor:
Rene Costello, William L. Dahut, Heather J. Chalfin, Seth M. Steinberg, David I. Quinn, Marissa Mallek, Jane B. Trepel, Ryan Dittamore, John Wright, Yipeng Wang, Robin Richardson, Adam Jendrisak, Jacqueline Cadena, James L. Gulley, Carlos Diaz, Tiziano Pramparo, Yen Lin Chu, Sumanta K. Pal, Rachel Krupa, Primo N. Lara, Olena Sierra Ortiz, Andrea B. Apolo, Howard Streicher, Amanda K. L. Anderson, Lisa M. Cordes, Donald P. Bottaro, Lisa Ley, Amir Mortazavi, Joseph D. Schonhoft, Mark N. Stein, Scot Anthony Niglio
Publikováno v:
Clinical Cancer Research. 27:1391-1398
Purpose: Circulating tumor cells (CTC) are under investigation as a minimally invasive liquid biopsy that may improve risk stratification and treatment selection. CTCs uniquely allow for digital pathology of individual malignant cell morphology and m
Autor:
Staci Martin, Maryalice Stetler-Stevenson, Sandhya R. Panch, Seth M. Steinberg, Steven L. Highfill, Haris Qureshi, Cindy Delbrook, Haiying Qin, Alina Dulau-Florea, Hao-Wei Wang, Crystal L. Mackall, Jianjian Jin, Constance M. Yuan, Lauren Little, Pamela L. Wolters, David F. Stroncek, Haneen Shalabi, Leah Hoffman, Dalia Salem, Terry J. Fry, Nirali N. Shah, Anusha Ponduri, Minh Tran, Bonnie Yates, Amanda K. Ombrello
Publikováno v:
J Clin Oncol
PURPOSE Patients with B-cell acute lymphoblastic leukemia who experience relapse after or are resistant to CD19-targeted immunotherapies have limited treatment options. Targeting CD22, an alternative B-cell antigen, represents an alternate strategy.
Autor:
Azam Ghafoor, Fang Wei, Udayan Guha, Wei Liao, Trinh Hoc Tran Pham, Mark Raffeld, Liqiang Xi, Seth M. Steinberg, Hadi Bagheri, Clive Morris, Nina Monkash, Gregory D. Jones, Jordan Cheng, Michael Tu, David Chia, Ahmad Shafiei, Constance M. Cultraro, Charles M. Strom, Vikram Misra, Elizabeth Akoth, Chul Kim, Nitin Roper, David T.W. Wong
Publikováno v:
Cancers
Cancers, vol 13, iss 13
Volume 13
Issue 13
Cancers, Vol 13, Iss 3342, p 3342 (2021)
Cancers, vol 13, iss 13
Volume 13
Issue 13
Cancers, Vol 13, Iss 3342, p 3342 (2021)
Simple Summary ctDNA assay is a promising non-invasive method to detect genomic alterations associated with lung cancer. In this prospective study of 25 patients with EGFR-mutant lung adenocarcinoma receiving osimertinib, ctDNA progression predated r
Autor:
Udo Rudloff, Christy Arrowood, Cara M. Kenney, Tricia F. Kunst, Santhana Webb, Edward J. Kim, Niharika B. Mettu, Devisser Christina, Seth M. Steinberg
Publikováno v:
Investigational new drugs, vol 39, iss 3
Investigational New Drugs
Investigational New Drugs
SummaryBackground Preclinical evidence has suggested that a subset of pancreatic cancers with the G12R mutational isoform of the KRAS oncogene is more sensitive to MAPK pathway blockade than pancreatic tumors with other KRAS isoforms. We conducted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9017c18e7dd9e6c059316e49d0d8915e
https://escholarship.org/uc/item/3520819s
https://escholarship.org/uc/item/3520819s
Autor:
Hong Zhou, Julie Feurtado, Hao-Wei Wang, Seth M. Steinberg, Chin-Hsien Tai, Mark Raffeld, Constance M. Yuan, Lacey James-Echenique, Evgeny Arons, Raul C. Braylan, Dai Chihara, Liqiang Xi, Alina Dulau-Florea, Katherine R. Calvo, Robert J. Kreitman, Keyur P. Patel, Maryalice Stetler-Stevenson, Irina Maric
Publikováno v:
Blood advances. 5(23)
Hairy cell leukemia variant (HCLv) responds poorly to purine analogue monotherapy. Rituximab concurrent with cladribine (CDAR) improves response rates, but long-term outcomes are unknown. We report final results of a phase 2 study of CDAR for patient
Autor:
Haneen Shalabi, Hao-Wei Wang, Kate Stringaris, Terry J. Fry, Jianjian Jin, Alina Dulau Florea, David F. Stroncek, Maryalice Stetler-Stevenson, Bonnie Yates, Yanyu Wang, Naomi Taylor, Lipei Shao, Jon Inglefield, Eytan Ruppin, Philip John Homan, Kim Dunham, Amanda K. Ombrello, Francesco Ceppi, Parthav Jailwala, Steven L. Highfill, Leandro C. Hermida, Constance M. Yuan, Welles Robinson, Fiorella Schischlik, Daniel A. Lichtenstein, Justin Mateen Mirazee, Ping Jin, Karen M. Chisholm, Seth M. Steinberg, Nirali N. Shah, Rebecca A. Gardner
Publikováno v:
Blood
Chimeric antigen receptor (CAR) T-cell toxicities resembling hemophagocytic lymphohistiocytosis (HLH) occur in a subset of patients with cytokine release syndrome (CRS). As a variant of conventional CRS, a comprehensive characterization of CAR T-cell
Autor:
Lisa M. Cordes, Margaret E. Gatti-Mays, Sofia R. Gameiro, Fatima Karzai, Claudia Palena, James L. Gulley, Seth M. Steinberg, Kristin C. Hicks, Karin M. Knudson, Renee N. Donahue, Jeffrey Schlom, Deneise C Francis, Yohei Ozawa, Stanley Lipkowitz, Caroline Jochems
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology
Frontiers in Oncology
Breast tumors commonly harbor low mutational burden, low PD-L1 expression, defective antigen processing/presentation, and an immunosuppressive tumor microenvironment (TME). In a malignancy mostly refractory to checkpoint blockade, there is an unmet c
Autor:
Orly Eshach Adiv, Liza Konnikova, Sarah Wall, Scott B. Snapper, Adi Mory, Dror S. Shouval, Ron Shaoul, Alina Kurolap, Alan R. Shuldiner, Claudia Gonzaga-Jauregui, Hagit Baris Feldman, Vanessa Mitsialis, Tamar Paperna, M. Steinberg, John D. Overton, Lael Werner, Moran Nunberg, Yaniv Zohar
Publikováno v:
Journal of Clinical Immunology. 39:430-439
This study aimed to characterize the clinical phenotype, genetic basis, and consequent immunological phenotype of a boy with severe infantile-onset colitis and eosinophilic gastrointestinal disease, and no evidence of recurrent or severe infections.